Furthermore, gene expression profiles of baicalein-treated non-small cell lung cancer cells unveiled the substantial downregulation of integrin alpha 1, 2, and 4 subunits, in agreement with anti-tumor growth in vivo [39]. This evidence concerns the gene ITGA1 and non-small cell lung carcinoma.